Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Badagnani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|July 15, 2006
Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2Ryan P Owen, Ilaria Badagnani, Kathleen M Giacomini
European Journal of Pharmacology|November 13, 2003
Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidneyLara M Mangravite, Ilaria Badagnani, Kathleen M Giacomini
Combinatorial Chemistry & High Throughput Screening|April 2, 2015
A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug DiscoveryLance Heinle, Vincent Peterkin, Sonia M de Morais, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2008
Differential effects of fibrates on the metabolic activation of 2-phenylpropionic acid in ratsChunze Li, Mark P Grillo, Ilaria Badagnani, et al.
Pharmacogenetics and Genomics|September 3, 2010
SLC19A1 pharmacogenomics summarySook Wah Yee, Li Gong, Ilaria Badagnani, et al.
Genome Research|December 16, 2005
Functional genomics of membrane transporters in human populationsThomas J Urban, Ronnie Sebro, Evan H Hurowitz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2022
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical SpeciesRhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Pharmacological Reviews|March 2, 2006
PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB networkIlaria Badagnani, Marco Sorani, Robert H Edwards, et al.
Molecular Cancer Therapeutics|June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug ConjugateShweta Singh, Laura Serwer, Amy DuPage, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|July 15, 2006
Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2Ryan P Owen, Ilaria Badagnani, Kathleen M Giacomini
European Journal of Pharmacology|November 13, 2003
Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidneyLara M Mangravite, Ilaria Badagnani, Kathleen M Giacomini
Combinatorial Chemistry & High Throughput Screening|April 2, 2015
A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug DiscoveryLance Heinle, Vincent Peterkin, Sonia M de Morais, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2008
Differential effects of fibrates on the metabolic activation of 2-phenylpropionic acid in ratsChunze Li, Mark P Grillo, Ilaria Badagnani, et al.
Pharmacogenetics and Genomics|September 3, 2010
SLC19A1 pharmacogenomics summarySook Wah Yee, Li Gong, Ilaria Badagnani, et al.
Genome Research|December 16, 2005
Functional genomics of membrane transporters in human populationsThomas J Urban, Ronnie Sebro, Evan H Hurowitz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2022
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical SpeciesRhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Pharmacological Reviews|March 2, 2006
PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB networkIlaria Badagnani, Marco Sorani, Robert H Edwards, et al.
Molecular Cancer Therapeutics|June 6, 2022
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug ConjugateShweta Singh, Laura Serwer, Amy DuPage, et al.
Pageof 2